Immunomedics (IMMU)
Add to Watchlists Create an AlertImmunomedics Enterprise Value:
238.01M for May 22, 2013Immunomedics Historical Enterprise Value Data
Pro Data ExportThere is no data for the selected date range.
| Data for this Date Range | |
|---|---|
| May 22, 2013 | 238.01M |
| May 21, 2013 | 238.84M |
| May 20, 2013 | 232.22M |
| May 17, 2013 | 238.01M |
| May 16, 2013 | 235.53M |
| May 15, 2013 | 229.74M |
| May 14, 2013 | 222.30M |
| May 13, 2013 | 208.23M |
| May 10, 2013 | 193.34M |
| May 9, 2013 | 190.04M |
| May 8, 2013 | 183.42M |
| May 7, 2013 | 178.46M |
| May 6, 2013 | 178.46M |
| May 3, 2013 | 181.76M |
| May 2, 2013 | 177.63M |
| May 1, 2013 | 176.80M |
| April 30, 2013 | 190.04M |
| April 29, 2013 | 185.90M |
| April 26, 2013 | 185.07M |
| April 25, 2013 | 187.55M |
| April 24, 2013 | 180.11M |
| April 23, 2013 | 188.38M |
| April 22, 2013 | 185.90M |
| April 19, 2013 | 183.42M |
| April 18, 2013 | 182.59M |
| April 17, 2013 | 185.07M |
| April 16, 2013 | 179.28M |
| April 15, 2013 | 173.49M |
| April 12, 2013 | 187.55M |
| April 11, 2013 | 190.86M |
| April 10, 2013 | 190.04M |
| April 9, 2013 | 184.25M |
| April 8, 2013 | 181.76M |
| April 5, 2013 | 192.52M |
| April 4, 2013 | 192.52M |
| April 3, 2013 | 192.52M |
| April 2, 2013 | 197.48M |
| April 1, 2013 | 180.11M |
| March 28, 2013 | 160.71M |
| March 27, 2013 | 156.92M |
| March 26, 2013 | 162.98M |
| March 25, 2013 | 160.71M |
| March 22, 2013 | 163.74M |
| March 21, 2013 | 159.19M |
| March 20, 2013 | 153.89M |
| March 19, 2013 | 158.44M |
| March 18, 2013 | 162.98M |
| March 15, 2013 | 166.01M |
| March 14, 2013 | 166.76M |
| March 13, 2013 | 167.14M |
About Enterprise Value
Click "Learn More" below to see how YCharts calculates Enterprise Value.
Enterprise Value (EV) is a valuation metric alternative to traditional market capitalization that reflects the market value of an entire business. Like market cap, EV is a measure of what the market believes a company is worth. Enterprise value captures the cost of an entire business, including debt and equity. It is a sum of claims of all preferred shareholders, debt holders, security holders, common equity holders, and minority shareholders - unlike market cap, which only captures the total value of common equity securities.
EV is considered the theoretical purchase ("takeover") price of a business because a purchaser would take on the company's debt, while pocketing the company's cash and gaining a right to all of the company's future earnings.
Learn More
IMMU Enterprise Value Benchmarks
| Companies | |
|---|---|
| Seattle Genetics | 3.869B |
| AVEO Pharmaceuticals | -53.62M |
| Threshold Pharmaceuticals | 203.38M |
IMMU Enterprise Value Rankings
| Overall |
61st percentile 3112 of 8006 |
| Sector |
55th percentile 307 of 686 in Healthcare |
| Industry |
66th percentile 84 of 248 in Biotechnology |
IMMU Enterprise Value Range, Past 5 Years
| Minimum | 26.54M | Mar 5 2009 |
| Maximum | 486.72M | Aug 27 2009 |
| Average | 206.79M |